Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ximedica, Theorem In Strategic Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News

Ximedica, Theorem In Strategic Alliance

Will work to design medical solutions that meet a range of safety requirements

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Theorem Clinical Research has entered a strategic alliance with Ximedica, a medical product development firm with expertise in human factors engineering, industrial design, mechanical, electrical and software engineering, advanced manufacturing services and regulatory requirements.
 
“Theorem works with Ximedica to create design solutions that meet the safety and use requirements of a wide range of populations, thereby minimizing risk during the regulatory review process,” said D. Lee Spurgin Jr., Ph.D., Theorem senior vice president and general manager of medical device and diagnostic development. “We feel these types of business alliances allow us to offer a better end product to clients.”
 
“Recognizing that a growing number of our product development programs are requiring large-scale, multi-center global clinical studies, it made sense for Ximedica to partner with a reputable, global CRO such as Theorem. Our combined expertise provides a more compelling solution for our global clients,” said Ximedica chief executive officer Randall S. Barko.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics